ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,433.74
0.23%
US Tech 100
19,089.60
0.65%
Dow Jones
38,647.10
-0.17%
Brent Oil
82.275
0.37%
Bitcoin
66,970.88
0.32%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
Unknown symbol
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
06/14/20243:00AMBusiness WireELREXFIO™ Shows Median Overall Survival of More Than Two Years in People with Relapsed or Refractory Multiple MyelomaNYSE:PFEPfizer Inc
06/14/20243:00AMGlobeNewswire Inc.Beam Therapeutics Reports Data Highlighting Optimized Manufacturing Process for BEAM-101, an Investigational Base Editing Therapeutic for Sickle Cell DiseaseNASDAQ:BEAMBeam Therapeutics Inc
06/14/20243:00AMGlobeNewswire Inc.Editas Medicine Announces New Safety and Efficacy Data from the EdiTHAL Trial of Reni-cel in 7 Patients with Transfusion-dependent Beta Thalassemia, Presented at the European Hematology Association (EHA) Annual CongressNASDAQ:EDITEditas Medicine Inc
06/14/20243:00AMBusiness WireImmune-Onc Therapeutics to Present Additional Positive Interim Data from IO-202 Phase 1b Expansion Cohort in Patients with Chronic Myelomonocytic Leukemia (CMML) at 2024 European Hematology Association (EHA) Annual Congress
06/14/20243:00AMBusiness WireNew Kite Clinical Research and Real-World Evidence for Yescarta® Demonstrate Benefit From Earlier Lines of TreatmentNASDAQ:GILDGilead Sciences Inc
06/14/20243:00AMGlobeNewswire Inc.Samsung Bioepis Presents Post-hoc Analysis of Phase 3 Study for EPYSQLI™ (SB12; Eculizumab Biosimilar), at the European Hematology Association (EHA) Congress 2024
06/14/20243:00AMPR Newswire (US)Brickken is selected to participate in the European Blockchain Regulatory Sandbox
06/14/20243:00AMPR Newswire (US)Top tips for retail store remodeling from the Paso Robles general contractor
06/14/20243:00AMPR Newswire (US)Protecting the vulnerable--Atascadero estate planning attorney on guardianships and conservatorships
06/14/20243:00AMPR Newswire (US)Brickken is selected to participate in the European Blockchain Regulatory Sandbox
06/14/20243:00AMPR Newswire (US)Getting a divorce when a spouse is missing, tips from We Help You Legal
06/14/20242:46AMAlliance NewsAlliance NewsLONDON BRIEFING: Bellway's planned takeover of Crest gets rejected
06/14/20242:46AMAlliance NewsAlliance NewsBridgerton boosts UK economy by GBP275 million, Netflix saysLSE:0QYINetflix Inc
06/14/20242:46AMPR Newswire (US)Expats soak up Duanwu fun in Shandong
06/14/20242:39AMAlliance NewsAlliance NewsSunak to tell G7 reform needed for sustainable development and AI
06/14/20242:36AMAlliance NewsAlliance NewsIrish election results complete after days of counting
06/14/20242:31AMAlliance NewsAlliance NewsDR Congo weighs legal move against Apple in mining disputeLSE:0R2VApple Inc
06/14/20242:30AMGlobeNewswire Inc.Renault Group: Implementation of the share buyback programmeBIT:RNORenault SA
06/14/20242:30AMGlobeNewswire Inc.Renault Group: Mise en œuvre du programme de rachat d’actionsBIT:RNORenault SA
06/14/20242:30AMGlobeNewswire Inc.Renault Group: Implementation of the share buyback programmeBIT:1RNORenault SA
06/14/20242:30AMGlobeNewswire Inc.Renault Group: Implementation of the share buyback programmeTG:RNLRenault SA
06/14/20242:30AMGlobeNewswire Inc.Renault Group: Mise en œuvre du programme de rachat d’actionsEU:RNORenault SA
06/14/20242:30AMGlobeNewswire Inc.Renault Group: Mise en œuvre du programme de rachat d’actionsBIT:1RNORenault SA
06/14/20242:30AMGlobeNewswire Inc.Renault Group: Mise en œuvre du programme de rachat d’actionsTG:RNLRenault SA
06/14/20242:30AMGlobeNewswire Inc.Vertex erwirbt Steuerfähigkeiten im Bereich der künstlichen Intelligenz von Ryan, LLCTG:56XVertex Inc
06/14/20242:30AMGlobeNewswire Inc.Renault Group: Implementation of the share buyback programmeEU:RNORenault SA
06/14/20242:29AMPR Newswire (US)The Safavi Impact Institute Sponsors NASA's Space Center Houston's pilot education program in Austria
06/14/20242:25AMGlobeNewswire Inc.RAMSAY SANTE :reprise des centres CosemLSE:0OD6Ramsay Generale De Sante Sa
06/14/20242:25AMGlobeNewswire Inc.RAMSAY SANTE :Cosem medical centers takeoverEU:GDSRamsay Generale De Sante
06/14/20242:25AMGlobeNewswire Inc.RAMSAY SANTE :reprise des centres CosemEU:GDSRamsay Generale De Sante

Your Recent History

USOTC
QSEP
QS Energy (PK)
USOTC
GTVH
Golden Triangle Ventures (PK)
USOTC
NLST
Netlist (QB)
USOTC
MWWC
Marketing Worldwide (PK)
USOTC
KEGS
1812 Brewing (PK)
NASDAQ
TSLA
Tesla
USOTC
RDGL
Vivos (QB)
USOTC
PHIL
PHI (PK)
USOTC
PPCB
Propanc Biopharma (PK)
USOTC
RSPI
RespireRx Pharmaceuticals (PK)
USOTC
VPLM
Voip Pal Com (QB)
USOTC
CGAC
Code Green Apparel (PK)
USOTC
IQST
iQSTEL (QX)
USOTC
IGPK
Intergrated Cannabis Sol... (PK)
USOTC
CYDY
CytoDyn (QB)
USOTC
CNNA
Cann American (CE)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved